SAM
DYN icon

Smartleaf Asset Management’s Dyne Therapeutics DYN Stock Holding History

Smartleaf Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1K Buy
769
+214
+39% +$3.69K ﹤0.01% 2186
2025
Q4 		$10.7K Buy
555
+472
+569% +$8.94K ﹤0.01% 2371
2025
Q3 		$1.03K Buy
83
+74
+822% +$844 ﹤0.01% 2742
2025
Q2 		$86 Buy
+9
New +$99 ﹤0.01% 2693
2025
Q1 		– Sell
-31
Closed -$733 – 2901
2024
Q4 		$733 Sell
31
-14
-31% -$414 ﹤0.01% 2723
2024
Q3 		$1.52K Buy
45
+13
+41% +$517 ﹤0.01% 2565
2024
Q2 		$1.13K Buy
+32
New +$930 ﹤0.01% 2385

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Smartleaf Asset Management's DYN Position: Q1 2026 in Review

Smartleaf Asset Management increased its Dyne Therapeutics (DYN) stake by 39% in Q1 2026, buying an estimated $3.69K and bringing the position to 769 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Smartleaf Asset Management first reported a position in DYN in Q2 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Smartleaf Asset Management held 769 shares of Dyne Therapeutics worth $13.1K as of Q1 2026.
  • Smartleaf Asset Management bought 214 Dyne Therapeutics shares in Q1 2026, an estimated $3.69K.
  • Dyne Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2186 holding.
  • Smartleaf Asset Management first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.